<DOC>
	<DOCNO>NCT02539082</DOCNO>
	<brief_summary>The primary objective study evaluate safety efficacy collagen injection patient plantar fasciitis</brief_summary>
	<brief_title>Safety Efficacy Collagen Injection Patients With Plantar Fasciitis</brief_title>
	<detailed_description>This study open-trial study . Sixty subject participate . The study explain subject voluntarily agree participate . Their eligibility participate study check , patient receive collagen placebo ( normal saline ) plantar facia randomization . They ask follow guideline investigator study visit hospital seven time , include screen date re-injection . . At visit , subject undergo VAS , clinical laboratory test , physical exam evaluate safety efficacy Regenseal . ( *Re-injection could maximum 2times visit2 3 , one week apart base investigator 's judgment initial injection . If subject get injection screening date , total number visit six . )</detailed_description>
	<mesh_term>Fasciitis</mesh_term>
	<mesh_term>Fasciitis , Plantar</mesh_term>
	<criteria>1 . Patient chronic plantar fasciitis ( Patients diagnose plantar fasciitis responsive noninvasive treatment three month ( noninvasive treatment include drug , physiotherapy shock wave , stretch ) 2 . Patients able complete questionnaire relate safety efficacy study drug read understood guideline 3 . Patients agree maintain medication dose study period need keep take . ( Excluded antiinflammatory analgesic drug pain injection . ) 4 . Patients agree use physical therapy shock wave study period . 5 . Patients representative ( adult ) , patient parent/guardian ( minor ) , agree participate study sign informed consent form 1 . If patient family suffer ever suffer autoimmune disease . 2 . Patients ever suffer anaphylactic reaction . 3 . Patients ever suffer hypersensitivity implant . 4 . Patients history allergy porcine bovine protein . 5 . Patients rheumatoid arthritis . 6 . Patients ankylose spondylitis . 7 . Patients suspect spinal deformity negative serum test 8 . Subjects pregnant and/or breastfeed and/or plan pregnancy . 9 . Subjects psychiatric disorder consider inappropriate participate trial Principal Investigator .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>collagen</keyword>
	<keyword>collagen injection</keyword>
	<keyword>plantar fasciitis</keyword>
</DOC>